Your agile partner for complex molecules

 

With research, development, and cGMP facilities across North America, Europe, and India, Eurofins CDMO offers integrated global platforms for small molecules and biologics from formulation and development to manufacturing. Our expertise spans monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), high-potent APIs, solid state R&D, and API drug product and manufacturing.

 

Our interconnected teams of scientific experts work collaboratively across sites to help pharmaceutical and biotech companies overcome complexity and bring therapies to market faster — delivering on our mission to move medicine forward.

 

Want to learn more? Watch our video!

Logo

Our global footprint

With strategically located facilities across North America, Europe and India, we are fully equipped to support your global drug development initiatives.

adobestock_582937126

North America

adobestock_720876443 (1)

Europe

adobestock_720145109-bceu002lap53849

India

Tuesday, May 27, 2025

Biologics brochure - Eurofins CDMO Alphora

Biologics services - North America

Tuesday, July 09, 2024

Eurofins CDMO Alphora Inc. (Canada) Announces Completion of New API Manufacturing Facility News

Eurofins CDMO is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility.

Wednesday, May 29, 2024

Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory News

Eurofins CDMO Alphora Inc. is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory

adobestock_528567825-1

Let's advance your innovation together